Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study.
Saved in:
| Title: | Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study. |
|---|---|
| Authors: | Rose, P.G.1, Java, J.2, Morgan, M.A.3, Secord, A.A.4, Kesterson, J.5, Stehman, F.B.6, Warshal, D.P.7, Creasman, W.T.8, Hanjani, P.9, Morris, R.T.10, Copeland, L.J.11 |
| Source: | Gynecologic Oncology. Jun2016 Supplement 1, Vol. 141, p207-208. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00908258 |
|---|---|
| DOI: | 10.1016/j.ygyno.2016.04.534 |
